Instil Bio, Inc. Debt Securities, Available-for-sale
Instil Bio, Inc. (TIL) had Debt Securities, Available-for-sale of $64.14 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-13
- 2026-06-30: Debt Securities, Available-for-sale $64.14M.
- 2026-03-31: Debt Securities, Available-for-sale $69.55M.
- 2025-12-31: Debt Securities, Available-for-sale $69.49M.
- 2025-09-30: Debt Securities, Available-for-sale $73.87M.
| Period end | Debt Securities, Available-for-sale | Debt Securities, Available-for-sale as first filed |
|---|---|---|
| 2026-06-30 | $64.14M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $69.55M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $69.49M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $73.87M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $84.14M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $88.29M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $104.51M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $113.69M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $141.82M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $148.30M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $141.16M 10-K · filed 2025-03-04 | $141.20M 10-K · filed 2024-03-21 |
| 2022-12-31 | $217.20M 10-K · filed 2024-03-21 | |
| 2021-12-31 | $416.50M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |